SAN DIEGO, May 8, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and CEO, Robert E. Hoffman, will present a corporate overview at the Sidoti Micro-Cap Virtual Conference being held on May 10 – 11, 2023.
Read more at prnewswire.comKintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here